Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Slingshot Biosciences

Slingshot Biosciences Launches TruCytes™ Potency CD20 & CD34 Stem Cell Gating Controls, Standardizing Critical Readouts While Slashing Variability, Time, and Cost
From Slingshot Biosciences
Via Business Wire
Slingshot Biosciences Appoints Glenn Bilawsky as CEO to Lead Strategic Expansion across Clinical Trial and Diagnostic Markets
From Slingshot Biosciences
Via Business Wire
Slingshot Biosciences Debuts TruCytes™ Potency—Cell Mimics for Scalable, Reproducible CAR-T Potency Assays
From Slingshot Biosciences
Via Business Wire
Slingshot Biosciences Welcomes Visionary Leader and Industry Expert Dr. Nimisha Srivastava as New Chief Operations Officer
From Slingshot Biosciences
Via Business Wire
Slingshot Unveils a Novel Cell Therapy-Focused Portfolio to Streamline Development while Improving Manufacturing and Clinical Trial Capabilities
From Slingshot Biosciences
Via Business Wire
Slingshot Biosciences Announces $11 Million in Series A3 Financing
From Slingshot Biosciences
Via Business Wire
Slingshot Biosciences Announces $23 Million in Series A Financing
From Slingshot Biosciences
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.